Skip to main content
OpenTrials
Completed

NCT Number: NCT02192632

Dermatologists' Educational Demonstration for Epiduo Application

The purpose of this study is to evaluate the efficacy and tolerability of this combination gel compared with BPO monotherapy in Korean patients, and test clinical practicability of dermatologists' educational demonstration for how to apply this gel in reducing uncomfortable irritations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dermatology, Seoul National University

Seoul, Joungro, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • mild to moderate acne were evaluated by Leeds revised acne grade from 2 to 6
  • age: 18-40

Exclusion criteria

  • pregnancy
  • mental illness
  • intake of oral isotretinoin within 6 months
  • application of the other oral or topical acne medications
  • chemical peeling or light based treatments within 6 weeks.

Treatment and study plan

Epiduo once daily with detailed instruction for how to apply it

Drug

Epiduo- once daily, simple instruction for application

Drug

BPO once daily

Drug

Primary outcomes

  1. Percentile reduction of non-inflammatory & inflammatory acne lesions

    Time frame: 12 weeks

    Measurement of decreases in both non-inflammatory & inflammatory acne lesions

Secondary outcomes

  1. Total number of local irriation effect counts (erythema, scaling, dryness, itching)

    Time frame: 12 week

    Calcuation of total number of local irriation effect counts (erythema, scaling, dryness, itching)

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jul 17, 2014
Registry last updated
Mar 17, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.